Showing results (931-940 of 3,072) with videos related to
Sort By:
Pageof 308
Chemotherapy|January 1, 1992
US experience with itraconazole in Aspergillus, Cryptococcus and Histoplasma infections in the immunocompromised hostJ S Hostetler, D W Denning, D A StevensChemotherapy|January 1, 1992
In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agentsJ Van CutsemChemotherapy|January 1, 1992
Antimicrobial activity of subinhibitory concentrations of ciprofloxacin against Pseudomonas aeruginosa as determined by the killing curve method and the postantibiotic effectG G Zhanel, J Crampton, S Kim, et al.Chemotherapy|January 1, 1992
Escherichia coli resistant to ampicillin/sulbactamR H Eng, K Yen, S M Smith, et al.Chemotherapy|January 1, 1992
Activity assays of thiadiazine derivatives on Trichomonas vaginalis and amastigote forms of Trypanosoma cruziJ Atienza, R A Martínez Díaz, A Gómez Barrio, et al.Chemotherapy|January 1, 1992
Effects of culture media on the in vitro susceptibility of selected opportunistic fungi to fluconazole and itraconazoleA S Sekhon, A A Padhye, A K Garg, et al.Chemotherapy|January 1, 1992
In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazoleE Martín, P Parras, M C LozanoChemotherapy|January 1, 1992
In vitro activity of sparfloxacin (CI-978), a new broad-spectrum fluoroquinoloneS M Qadri, Y Ueno, J J Burns, et al.Chemotherapy|December 13, 2003
Correlation of meropenem plasma levels with pharmacodynamic requirements in critically ill patients receiving continuous veno-venous hemofiltrationWolfgang A Krueger, Gertraud Neeser, Harald Schuster, et al.Chemotherapy|December 13, 2003
Postantibiotic and sub-MIC effects of benzylpenicillin against Streptococcus pneumoniae with different susceptibilities for penicillinInga Odenholt, Ingegerd Gustafsson, Elisabeth LöwdinPageof 308